Huntington National Bank Acadia Pharmaceuticals Inc Transaction History

Huntington National Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$17.79 - $30.86 $889 - $1,543	50 New	50 $0
Q2 2020 Jul 30, 2020	SELL	$39.26 - $52.73 $40,241 - $54,048	-1,025 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$36.21 - $51.4 $37,115 - $52,685	1,025 New	1,025 $44,000
Q1 2019 Apr 09, 2019	SELL	$16.17 - $27.38 $1,617 - $2,738	-100 Closed	0 $0
Q4 2018 Jan 28, 2019	BUY	$14.32 - $22.92 $1,432 - $2,292	100 New	100 $2,000

281

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.79B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

Stay updated on Huntington National Bank with notifications on news.